FDA Lands Duke’s Califf As Top Deputy, Potential Next Commissioner
This article was originally published in The Pink Sheet Daily
Executive Summary
Renowned cardiologist and clinical trialist Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco.
You may also be interested in...
The Evolving Door? What Having A ‘Big Data’ Commissioner Might Mean For US FDA
Robert Califf’s nomination to return as FDA commissioner will raise protests about a ‘revolving door’ pathway between industry and agency. But, in this case, it may be more apt to talk about how Califf’s time outside FDA led to evolving views on the role of big data in drug regulation.
Califf Maintains Desire To Stay At FDA, But Would Either Presidential Candidate Keep Him?
FDA Commissioner says every day at FDA is fun, but decision to remain will be made by the next president.
Finally … Rachel Sherman Takes Califf's Old FDA Job
After months of speculation, FDA veteran Rachel Sherman becomes deputy commissioner for medical products and tobacco.